Purpose: Intensive hypotension is an important technique in neurosurgical perioperative management. However, it could decrease urine volume, and induce fluid retention resulting in cardiac failure. We evaluated the efficacy of human atrial natriuretic peptide (hANP) on diuresis in a hypotensive condition.
Methods: In 245 patients undergoing neurosurgical operations under general anesthesia in our hospital, 26 patients demonstrated a urine volume less than 50 ml/h at 1 hour after the skin incision, despite receiving a large volume of intravenous fluid. In these 26 patients, we administered hANP (0.05 microg/kg/min) continuously, and evaluated the effect of hANP on diuresis in a hypotensive condition.
Results: After the administration of hANP, the urine volume increased significantly (p<0.01) from 28.7 to 229.4 (ml/h, mean). The heart rate increased from 66.6 to 71.7 (bpm, mean), whereas the systolic blood pressure decreased from 110.3 to 102.2 (mmHg, mean). The electrocardiogram did not change during the administration of hANP.
Conclusions: Despite the hypotensive condition, hANP showed a strong diuretic effect in our study. In neurosurgical perioperative management, administration of hANP can be a useful tool for a fluid balance in the patient.
Download full-text PDF |
Source |
---|
Afr J Reprod Health
December 2024
Department of Medical Laboratory, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
This was an original article, and the objective of this study was to investigate the effects of bipolar transurethral plasma kinetic prostatectomy (TUPKP) on urodynamics and sexual function in benign prostatic hyperplasia (BPH) patients. One hundred and four BPH patients were divided into a control group and an intervention group. The control group received transurethral resection of prostate, while the intervention group received TUKEP.
View Article and Find Full Text PDFJ Clin Med
December 2024
The Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
Even in current guideline-directed medical therapy, including recently introduced vasopressin type 2 receptor antagonist tolvaptan, congestion has not been resolved in patients with heart failure. Kampo medicine goreisan has been receiving considerable attention as an additional therapy for patients who are refractory to conventional diuretics therapy, including tolvaptan. However, the impact of goreisan on urine electrolytes remains uncertain.
View Article and Find Full Text PDFBiomedicines
December 2024
Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
: The aim of the study was to assess the effect of high-intensity focused electromagnetic (HIFEM) technology in the treatment of female stress urinary incontinence (SUI). : 20 women with SUI were delivered a treatment course with HIFEM technology. Patients attended 6 therapies scheduled twice a week.
View Article and Find Full Text PDFInt Neurourol J
December 2024
Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Purpose: We aimed to assess the clinical efficacy and safety of combining silodosin and solifenacin for overactive bladder (OAB) in females.
Methods: A retrospective analysis of 586 females with OAB was conducted. Patients received either combination therapy (silodosin 8 mg + solifenacin 5 mg) or monotherapy (solifenacin 5 mg) for 12 weeks.
Low Urin Tract Symptoms
January 2025
Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Objectives: This study aimed to evaluate the clinical efficacy and safety of silodosin in female patients with lower urinary tract symptoms (LUTSs), addressing the limited evidence supporting alpha-blocker use in this population.
Methods: A 12-week, single-arm, prospective, open-label study was conducted from May 2021 to January 2023. Female patients aged over 18 with an International Prostate Symptom Score (IPSS) ≥ 8 were enrolled and treated with silodosin (8 mg once daily).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!